Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille B Carroll

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 11, 2004
Do on-off variations cause discrepancies in the historical items of the UPDRS?Camille B Carroll, Peter G Bain
Journal of Parkinson'S Disease|October 18, 2017
Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current ProgressCamille B Carroll, Richard K H Wyse
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2019
Statins and Parkinson's: A complex interactionCamille B Carroll, Richard K H Wyse, Donald G Grosset
BMJ Open|January 22, 2025
Digital health technologies and self-efficacy in Parkinson's: a scoping reviewAndrew Michael Hall, Victoria Allgar, Camille B Carroll, et al.
Frontiers in Neurology|November 29, 2023
A modular, deep learning-based holistic intent sensing system tested with Parkinson's disease patients and controlsJoseph Russell, Jemma Inches, Camille B Carroll, et al.
BMJ Open|March 23, 2023
Impact of digital technologies on self-efficacy in people with Parkinson's: a scoping review protocolAndrew Michael Hall, S Aroori, Camille B Carroll, et al.
Journal of Neuroscience Methods|April 26, 2005
Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasksXuguang Liu, Camille B Carroll, Shou-Yan Wang, et al.
Journal of Parkinson'S Disease|November 26, 2023
An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson's Disease TrialsMarie-Louise Zeissler, Kevin McFarthing, Karen G Raphael, et al.
Oncotarget|July 2, 2016
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesisMarie-Louise Zeissler, Jordan Eastwood, Kieran McCorry, et al.
Neurodegenerative Disease Management|July 6, 2018
Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialistsRobin Fackrell, Camille B Carroll, Donald G Grosset, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Movement Disorders : Official Journal of the Movement Disorder Society|May 11, 2004
Do on-off variations cause discrepancies in the historical items of the UPDRS?Camille B Carroll, Peter G Bain
Journal of Parkinson'S Disease|October 18, 2017
Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current ProgressCamille B Carroll, Richard K H Wyse
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2019
Statins and Parkinson's: A complex interactionCamille B Carroll, Richard K H Wyse, Donald G Grosset
BMJ Open|January 22, 2025
Digital health technologies and self-efficacy in Parkinson's: a scoping reviewAndrew Michael Hall, Victoria Allgar, Camille B Carroll, et al.
Frontiers in Neurology|November 29, 2023
A modular, deep learning-based holistic intent sensing system tested with Parkinson's disease patients and controlsJoseph Russell, Jemma Inches, Camille B Carroll, et al.
BMJ Open|March 23, 2023
Impact of digital technologies on self-efficacy in people with Parkinson's: a scoping review protocolAndrew Michael Hall, S Aroori, Camille B Carroll, et al.
Journal of Neuroscience Methods|April 26, 2005
Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasksXuguang Liu, Camille B Carroll, Shou-Yan Wang, et al.
Journal of Parkinson'S Disease|November 26, 2023
An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson's Disease TrialsMarie-Louise Zeissler, Kevin McFarthing, Karen G Raphael, et al.
Oncotarget|July 2, 2016
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesisMarie-Louise Zeissler, Jordan Eastwood, Kieran McCorry, et al.
Neurodegenerative Disease Management|July 6, 2018
Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialistsRobin Fackrell, Camille B Carroll, Donald G Grosset, et al.
Pageof 3